Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

New methods for determining comparative effectiveness in rheumatoid arthritis.

Yun H, Curtis JR.

Curr Opin Rheumatol. 2013 May;25(3):325-33. doi: 10.1097/BOR.0b013e32835fd8c0. Review.

2.

Comparative effectiveness research (CER): a summary of AHRQ's CER on therapies for rheumatoid arthritis.

Oderda GM, Balfe LM.

J Manag Care Pharm. 2011 Nov-Dec;17(9 Suppl B):S19-24.

3.

Summary of AHRQ's comparative effectiveness review of drug therapy for rheumatoid arthritis (RA) in adults--an update.

Singh JA, Cameron DR.

J Manag Care Pharm. 2012 May;18(4 Supp C):S1-18. Review.

PMID:
22656072
4.

Review of head-to-head study designs in rheumatoid arthritis.

R F, R L, J S S.

Semin Arthritis Rheum. 2016 Dec;46(3):279-285. doi: 10.1016/j.semarthrit.2016.07.006. Epub 2016 Aug 1. Review.

5.

Comparative effectiveness research with administrative health data in rheumatoid arthritis.

Hudson M, Tascilar K, Suissa S.

Nat Rev Rheumatol. 2016 Jun;12(6):358-66. doi: 10.1038/nrrheum.2016.34. Epub 2016 Apr 15. Review.

PMID:
27080692
6.

Indirect and mixed treatment comparisons in arthritis research.

Ades AE, Madan J, Welton NJ.

Rheumatology (Oxford). 2011 Sep;50 Suppl 4:iv5-9. doi: 10.1093/rheumatology/ker241. Review.

PMID:
21859707
7.

A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.

Chen YF, Jobanputra P, Barton P, Jowett S, Bryan S, Clark W, Fry-Smith A, Burls A.

Health Technol Assess. 2006 Nov;10(42):iii-iv, xi-xiii, 1-229. Review.

8.

The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis.

Clark W, Jobanputra P, Barton P, Burls A.

Health Technol Assess. 2004 May;8(18):iii-iv, ix-x, 1-105. Review.

9.

Biologic rheumatoid arthritis therapies: do we need more comparative effectiveness data?

Levesque MC.

BioDrugs. 2012 Apr 1;26(2):65-70. doi: 10.2165/11631320-000000000-00000.

PMID:
22385403
10.

Treatment comparison in rheumatoid arthritis: head-to-head trials and innovative study designs.

Favalli EG, Bugatti S, Biggioggero M, Caporali R.

Biomed Res Int. 2014;2014:831603. doi: 10.1155/2014/831603. Epub 2014 Apr 16. Review.

11.
12.

Comparative effectiveness of current treatments for rheumatoid arthritis.

Gibofsky A.

Am J Manag Care. 2012 Dec;18(13 Suppl):S303-14.

13.

Can we improve the performance and reporting of investigator-initiated clinical trials? Rheumatoid arthritis as an example.

Landewé RB, Smolen JS, Weinblatt ME, Emery P, Dougados M, Fleischmann R, Aletaha D, Kavanaugh A, van der Heijde D.

Ann Rheum Dis. 2014 Oct;73(10):1755-60. doi: 10.1136/annrheumdis-2014-205821. Epub 2014 Aug 11.

PMID:
25114058
14.

Systematic review of tumor necrosis factor inhibitor discontinuation studies in rheumatoid arthritis.

Navarro-Millán I, Sattui SE, Curtis JR.

Clin Ther. 2013 Nov;35(11):1850-61.e1. doi: 10.1016/j.clinthera.2013.09.015. Epub 2013 Oct 22. Review.

15.

Can CER be an effective tool for change in the development and assessment of new drugs and technologies?

Brixner DI, Watkins JB.

J Manag Care Pharm. 2012 Jun;18(5 Supp A):S06-11.

PMID:
22663293
16.

The methods of comparative effectiveness research.

Sox HC, Goodman SN.

Annu Rev Public Health. 2012 Apr;33:425-45. doi: 10.1146/annurev-publhealth-031811-124610. Epub 2012 Jan 3. Review.

PMID:
22224891
17.

Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA).

Singh JA, Hossain A, Tanjong Ghogomu E, Mudano AS, Tugwell P, Wells GA.

Cochrane Database Syst Rev. 2016 Nov 17;11:CD012437. Review.

PMID:
27855242
18.

Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis.

Singh JA, Hossain A, Tanjong Ghogomu E, Kotb A, Christensen R, Mudano AS, Maxwell LJ, Shah NP, Tugwell P, Wells GA.

Cochrane Database Syst Rev. 2016 May 13;(5):CD012183. doi: 10.1002/14651858.CD012183. Review.

PMID:
27175934
19.

Some methodological points to consider when performing systematic reviews in comparative effectiveness research.

Berlin JA, Cepeda MS.

Clin Trials. 2012 Feb;9(1):27-34. doi: 10.1177/1740774511427062. Epub 2011 Nov 2.

PMID:
22049086
20.

Network meta-analysis for comparing treatment effects of multiple interventions: an introduction.

Catalá-López F, Tobías A, Cameron C, Moher D, Hutton B.

Rheumatol Int. 2014 Nov;34(11):1489-96. doi: 10.1007/s00296-014-2994-2. Epub 2014 Apr 2. Review.

PMID:
24691560

Supplemental Content

Support Center